Global Gout Therapeutics Market Size, Status and Forecast 2025

 Publisher : Globainforesearch.biz  
  Report ID : 49921   
 Published On : July 2018  
 Pages : 95 
 Format : PDF
 Category : Medical Care
 Publisher: QY Research
  Report ID : 49921      Published On: July 2018      Pages:95      Format:PDF

This report studies the global Gout Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Gout Therapeutics market by companies, region, type and end-use industry. Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market. At present, the Americas is the largest market for gout therapeutics and is estimated to retain its hold over the market until the end of 2020. The market in this region is growing briskly due to the higher incidences of gout in the US, which results in the growing consumption of gout drugs. In this region, novel therapies like llaris and lesinurad FDC are expected to launch during the forecast period in the US as they have proven benefits over the standard of care. This indicates that novel therapies will have a favorable market potential and good market success during the forecast period. In 2017, the global Gout Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global top players, covered Takeda Pharmaceutical Company Novartis AstraZeneca GlaxoSmithKline Merck Regeneron Pharmaceuticals ... Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Market segment by Type, the product can be split into NSAIDs Corticosteroids Colchicine Urate-Lowering Agents Market segment by Application, split into Acute Gout Chronic Gout The study objectives of this report are: To study and forecast the market size of Gout Therapeutics in global market. To analyze the global key players, SWOT analysis, value and global market share for top players. To define, describe and forecast the market by type, end use and region. To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World. To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Gout Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Gout Therapeutics Manufacturers Gout Therapeutics Distributors/Traders/Wholesalers Gout Therapeutics Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Gout Therapeutics market, by end-use. Detailed analysis and profiles of additional market players.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents Global Gout Therapeutics Market Size, Status and Forecast 2025 1 Industry Overview of Gout Therapeutics 1.1 Gout Therapeutics Market Overview 1.1.1 Gout Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Gout Therapeutics Market Size and Analysis by Regions (2013-2018) 1.2.1 United States 1.2.2 Europe 1.2.3 China 1.2.4 Japan 1.2.5 Southeast Asia 1.2.6 India 1.3 Gout Therapeutics Market by Type 1.3.1 NSAIDs 1.3.2 Corticosteroids 1.3.3 Colchicine 1.3.4 Urate-Lowering Agents 1.4 Gout Therapeutics Market by End Users/Application 1.4.1 Acute Gout 1.4.2 Chronic Gout 2 Global Gout Therapeutics Competition Analysis by Players 2.1 Gout Therapeutics Market Size (Value) by Players (2013-2018) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Takeda Pharmaceutical Company 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 3.3 AstraZeneca 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 3.4 GlaxoSmithKline 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 3.5 Merck 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 3.6 Regeneron Pharmaceuticals 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Gout Therapeutics Revenue (Million USD) (2013-2018) 4 Global Gout Therapeutics Market Size by Type and Application (2013-2018) 4.1 Global Gout Therapeutics Market Size by Type (2013-2018) 4.2 Global Gout Therapeutics Market Size by Application (2013-2018) 4.3 Potential Application of Gout Therapeutics in Future 4.4 Top Consumer/End Users of Gout Therapeutics 5 United States Gout Therapeutics Development Status and Outlook 5.1 United States Gout Therapeutics Market Size (2013-2018) 5.2 United States Gout Therapeutics Market Size and Market Share by Players (2013-2018) 5.3 United States Gout Therapeutics Market Size by Application (2013-2018) 6 Europe Gout Therapeutics Development Status and Outlook 6.1 Europe Gout Therapeutics Market Size (2013-2018) 6.2 Europe Gout Therapeutics Market Size and Market Share by Players (2013-2018) 6.3 Europe Gout Therapeutics Market Size by Application (2013-2018) 7 China Gout Therapeutics Development Status and Outlook 7.1 China Gout Therapeutics Market Size (2013-2018) 7.2 China Gout Therapeutics Market Size and Market Share by Players (2013-2018) 7.3 China Gout Therapeutics Market Size by Application (2013-2018) 8 Japan Gout Therapeutics Development Status and Outlook 8.1 Japan Gout Therapeutics Market Size (2013-2018) 8.2 Japan Gout Therapeutics Market Size and Market Share by Players (2013-2018) 8.3 Japan Gout Therapeutics Market Size by Application (2013-2018) 9 Southeast Asia Gout Therapeutics Development Status and Outlook 9.1 Southeast Asia Gout Therapeutics Market Size (2013-2018) 9.2 Southeast Asia Gout Therapeutics Market Size and Market Share by Players (2013-2018) 9.3 Southeast Asia Gout Therapeutics Market Size by Application (2013-2018) 10 India Gout Therapeutics Development Status and Outlook 10.1 India Gout Therapeutics Market Size (2013-2018) 10.2 India Gout Therapeutics Market Size and Market Share by Players (2013-2018) 10.3 India Gout Therapeutics Market Size by Application (2013-2018) 11 Market Forecast by Regions, Type and Application (2018-2025) 11.1 Global Gout Therapeutics Market Size (Value) by Regions (2018-2025) 11.1.1 United States Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.1.2 Europe Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.1.3 China Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.1.4 Japan Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.1.5 Southeast Asia Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.1.6 India Gout Therapeutics Revenue and Growth Rate (2018-2025) 11.2 Global Gout Therapeutics Market Size (Value) by Type (2018-2025) 11.3 Global Gout Therapeutics Market Size by Application (2018-2025) 12 Gout Therapeutics Market Dynamics 12.1 Gout Therapeutics Market Opportunities 12.2 Gout Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Gout Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Gout Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source  
List of Tables and Figures Figure Global Gout Therapeutics Market Size (Million USD) Status and Outlook (2013-2018) Table Global Gout Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018) Figure Global Gout Therapeutics Market Share by Regions (2013-2018) Figure United States Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Europe Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure China Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Japan Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Southeast Asia Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure India Gout Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Table Global Gout Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018) Figure Global Gout Therapeutics Revenue Market Share by Type in 2017 Figure NSAIDs Market Size (Million USD) and Growth Rate (2013-2018) Figure Corticosteroids Market Size (Million USD) and Growth Rate (2013-2018) Figure Colchicine Market Size (Million USD) and Growth Rate (2013-2018) Figure Urate-Lowering Agents Market Size (Million USD) and Growth Rate (2013-2018) Figure Global Gout Therapeutics Market Share by Application in 2017 Figure Gout Therapeutics Market Size (Million USD) and Growth Rate in Acute Gout (2013-2018) Figure Gout Therapeutics Market Size (Million USD) and Growth Rate in Chronic Gout (2013-2018) Figure Gout Therapeutics Market Size (Million USD) and Growth Rate in Applications 3 (2013-2018) Table Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Gout Therapeutics Market Size Share by Players in 2013 Figure Gout Therapeutics Market Size Share by Players in 2017 Table Takeda Pharmaceutical Company Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical Company (2013-2018) Figure Takeda Pharmaceutical Company Gout Therapeutics Business Revenue Market Share (2013-2018) Table Novartis Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of Novartis (2013-2018) Figure Novartis Gout Therapeutics Business Revenue Market Share (2013-2018) Table AstraZeneca Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of AstraZeneca (2013-2018) Figure AstraZeneca Gout Therapeutics Business Revenue Market Share (2013-2018) Table GlaxoSmithKline Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018) Figure GlaxoSmithKline Gout Therapeutics Business Revenue Market Share (2013-2018) Table Merck Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of Merck (2013-2018) Figure Merck Gout Therapeutics Business Revenue Market Share (2013-2018) Table Regeneron Pharmaceuticals Basic Information List Table Gout Therapeutics Business Revenue (Million USD) of Regeneron Pharmaceuticals (2013-2018) Figure Regeneron Pharmaceuticals Gout Therapeutics Business Revenue Market Share (2013-2018) Table Global Gout Therapeutics Market Size (Million USD) by Product (2013-2018) Figure Global Gout Therapeutics Revenue Market Share (%) by Product (2013-2018) Figure Global Gout Therapeutics Market Share by Product in 2017 Table Global Gout Therapeutics Market Size by Application (2013-2018) Figure Global Gout Therapeutics Revenue Market Share (%) by Application in 2017 Table Top Consumer/End Users of Gout Therapeutics Figure United States Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table United States Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure United States Gout Therapeutics Market Size Share by Players in 2013 Figure United States Gout Therapeutics Market Size Share by Players in 2017 Table United States Gout Therapeutics Market Size by Application (2013-2018) Figure United States Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure United States Gout Therapeutics Market Size Share by Application in 2017 Figure Europe Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Europe Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Europe Gout Therapeutics Market Size Share by Players in 2013 Figure Europe Gout Therapeutics Market Size Share by Players in 2017 Table Europe Gout Therapeutics Market Size by Application (2013-2018) Figure Europe Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Europe Gout Therapeutics Market Size Share by Application in 2017 Figure China Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table China Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure China Gout Therapeutics Market Size Share by Players in 2013 Figure China Gout Therapeutics Market Size Share by Players in 2017 Table China Gout Therapeutics Market Size by Application (2013-2018) Figure China Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure China Gout Therapeutics Market Size Share by Application in 2017 Figure Japan Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Japan Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Japan Gout Therapeutics Market Size Share by Players in 2013 Figure Japan Gout Therapeutics Market Size Share by Players in 2017 Table Japan Gout Therapeutics Market Size by Application (2013-2018) Figure Japan Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Japan Gout Therapeutics Market Size Share by Application in 2017 Figure Southeast Asia Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Southeast Asia Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Southeast Asia Gout Therapeutics Market Size Share by Players in 2013 Figure Southeast Asia Gout Therapeutics Market Size Share by Players in 2017 Table Southeast Asia Gout Therapeutics Market Size by Application (2013-2018) Figure Southeast Asia Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Southeast Asia Gout Therapeutics Market Size Share by Application in 2017 Figure India Gout Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table India Gout Therapeutics Market Size (Million USD) by Players (2013-2018) Figure India Gout Therapeutics Market Size Share by Players in 2013 Figure India Gout Therapeutics Market Size Share by Players in 2017 Table India Gout Therapeutics Market Size by Application (2013-2018) Figure India Gout Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure India Gout Therapeutics Market Size Share by Application in 2017 Figure Global Gout Therapeutics Market Size and Growth Rate (2018-2025) Table Global Gout Therapeutics Market Size (Million USD) by Regions (2018-2025) Figure Global Gout Therapeutics Market Size Share (2018-2025) Figure Global Gout Therapeutics Market Size Share by Regions in 2025 Figure United States Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Europe Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure China Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Japan Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Southeast Asia Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure India Gout Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Table Global Gout Therapeutics Market Size (Million USD) by Type (2018-2025) Figure Global Gout Therapeutics Market Size Share by Type in 2018 Figure Global Gout Therapeutics Market Size Share by Type in 2025 Table Global Gout Therapeutics Market Size (Million USD) by Application (2018-2025) Figure Global Gout Therapeutics Market Size (Million USD) by Application in 2018

Note: If you have any special requirements, please let us know and we will offer you the report as you want.





We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.





We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.

Our Clients

microsoft
microsoft
microsoft
microsoft
microsoft
microsoft
microsoft
microsoft
michelin
kpmg
gaf
kawasaki
Contact Us
Call Now